PREPARATION OF MONOCLONAL ANTIBODIES FOR DETECTION OF RECOMBINANT FLAGELLIN C FROM PSEUDOMONAS AERUGINOSA

被引:0
|
作者
Zherebtsov, A. P. [1 ]
Yakovleva, I., V [2 ]
Gavrilova, N. F. [2 ]
Mikhailova, N. A. [1 ]
机构
[1] I Mechnikov Res Inst Vaccines & Sera, Lab Protect Antigens, Moscow, Russia
[2] I Mechnikov Res Inst Vaccines & Sera, Lab Therapeut Vaccines, Moscow, Russia
来源
INFEKTSIYA I IMMUNITET | 2024年 / 14卷 / 03期
关键词
P; aeruginosa; flagellin; recombinant FliC protein; monoclonal antibodies; mAb; hybridoma-producer;
D O I
10.15789/2220-7619-POM-16865
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
An important virulence factor in the pathogenesis of infections caused by Pseudomonas aeruginosa is flagellin: it serves as the main structural component of the bacterial flagellum and an acceptor for the TLR5 receptor of the innate immune system. Toll-like receptor 5 is able to bind bacterial flagellin and activate the anti-inflammatory transcription factor NF-kappa B kappa B through the adapter protein MyD88, which induces the production of anti-inflammatory cytokines. The inclusion of flagellin in recombinant proteins increased the ability to stimulate the production of antiinflammatory cytokines and activate antigen-presenting cells. A number of experiments have shown that the use of flagellin as a molecular adjuvant in vaccines increases the expression of CD80, CD83, CD86 and MHC II molecules on the surface of dendritic cells, and also leads to an increase in the secretion of IFN gamma gamma and alpha-defensins by dendritic and NK cells; T cell proliferation and activation of antigen-specific cytotoxic T lymphocytes, as well as increased induction of antigen-specific IgG and IgA antibodies. Due to the natural and acquired resistance of P. aeruginosa to antibiotics, the available choice of antipseudomonas drugs is decreasing, and therefore the problem of developing effective therapeutic drugs to protect against this infection is of high medical and social importance. For this purpose, it seems promising to study the immunobiological properties of P. aeruginosa flagellin as a possible vaccine component. Based on this, in the Laboratory of Protective Antigens of the I. Mechnikov Research Institute of Vaccines and Sera, recombinant flagellin C (FliC) of P. aeruginosa was obtained, and its immunogenicity and protective properties were proven. However, the question of standardizing methods for screening and monitoring the resulting recombinant FliC protein remains open. To solve this issue, hybridomas producing monoclonal antibodies (mAb) of a given specificity were obtained, the basic immunochemical properties of mAbs were studied, and the possibility of using them as reagents in constructing a test system for identifying and standardizing the recombinant FliC protein upon its production was assessed. Purpose of the work: to obtain monoclonal antibodies to the recombinant flagellin C protein of P. aeruginosa; ; to study their basic immunochemical properties and to evaluate the possibility of using the recombinant FliC protein for screening and control.
引用
收藏
页码:551 / 556
页数:6
相关论文
共 50 条
  • [41] Detection of Pseudomonas aeruginosa type III antibodies in children with tracheostomies
    Rao, AR
    Splaingard, MS
    Gershan, WM
    Havens, PL
    Thill, A
    Barbieri, JT
    PEDIATRIC PULMONOLOGY, 2005, 39 (05) : 402 - 407
  • [42] Characterization of monoclonal antibodies against altered (T103I) amidase from Pseudomonas aeruginosa
    Sónia Martins
    Amin Karmali
    Jorge Andrade
    Ana Custódio
    Maria Luísa Serralheiro
    Molecular Biotechnology, 2005, 30 (3) : 207 - 219
  • [43] Detection of antibodies to Pseudomonas aeruginosa in serum and oral fluid from patients with cystic fibrosis
    Weisner, Abbie M.
    Chart, Henrik
    Bush, Andrew
    Davies, Jane C.
    Pitt, Tyrone L.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 56 (05) : 670 - 674
  • [44] Preparation and characterization of monoclonal and recombinant antibodies specific to the insecticide malathion
    Nishi, K
    Imajuku, Y
    Nakata, M
    Ohde, K
    Miyake, S
    Morimune, K
    Kawata, M
    Ohkawa, H
    JOURNAL OF PESTICIDE SCIENCE, 2003, 28 (03): : 301 - 309
  • [45] Preparation and identification of monoclonal antibodies against recombinant human thioredoxins
    Tang, Wen-Xin
    Chen, Xiao-Ping
    Zhao, Yan-Ying
    Wang, Jian-He
    Wang, Wei
    Chen, Zheng-Wang
    HYBRIDOMA, 2007, 26 (05): : 338 - 341
  • [46] Antibodies raised against N′-terminal Pseudomonas aeruginosa flagellin prevent mortality in lethal murine models of infection
    Neville, LF
    Barnea, Y
    Hammer-Munz, O
    Gur, E
    Kuzmenko, B
    Kahel-Raifer, H
    Eren, R
    Elkeles, A
    Murthy, KGK
    Szabó, C
    Salzman, AL
    Dagan, S
    Carmeli, Y
    Navon-Venezia, S
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2005, 16 (01) : 165 - 171
  • [47] Purification, crystallization and X-ray crystallographic studies of flagellin from Pseudomonas aeruginosa
    Song, Wan Seok
    Hong, Minsun
    Yoon, Sung-il
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2014, 70 : 200 - 202
  • [48] MONOCLONAL-ANTIBODIES PROVIDE PROTECTION AGAINST OCULAR PSEUDOMONAS-AERUGINOSA INFECTION
    MOON, MM
    HAZLETT, LD
    HANCOCK, REW
    BERK, RS
    BARRETT, R
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1988, 29 (08) : 1277 - 1284
  • [49] PRODUCTION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES TO PSEUDOMONAS-AERUGINOSA EXOENZYME-S
    MARKOWITZ, AB
    FENDLY, BM
    LILE, JK
    IGLEWSKI, BH
    LARRICK, JW
    CLINICAL RESEARCH, 1987, 35 (03): : A428 - A428
  • [50] HUMAN MONOCLONAL-ANTIBODIES THAT PROTECT MICE AGAINST CHALLENGE WITH PSEUDOMONAS-AERUGINOSA
    ZWEERINK, HJ
    GAMMON, MC
    HUTCHISON, CF
    JACKSON, JJ
    LOMBARDO, D
    MINER, KM
    PUCKETT, JM
    SEWELL, TJ
    SIGAL, NH
    INFECTION AND IMMUNITY, 1988, 56 (08) : 1873 - 1879